(firstQuint)A Phase 3, Double-Blind 2 Arm Study in the Treatment of Acne Vulgaris.

 This is a multi-center, randomized, double-blind, vehicle-controlled, 12-week study designed to assess the safety, efficacy, and tolerability of IDP-123 Lotion and IDP-123Vehicle Lotion.

 To be eligible for the study subjects must be at least 9 years of age and have a clinical diagnosis of moderate to severe acne.

.

 A Phase 3, Double-Blind 2 Arm Study in the Treatment of Acne Vulgaris@highlight

This is a multicenter, randomized, double-blind, vehicle-controlled study designed to assess the safety, efficacy, and tolerability of IDP-123 Lotion in comparison with IDP-123 Vehicle Lotion.

